Has Vernon Sutton received payments from drug or device companies?

Yes. Drug and device makers reported $90,190 in general payments to Vernon Sutton across 70 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Vernon Sutton did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Vernon Sutton come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Vernon Sutton

Pediatrics · Houston, TXNPI 1104906445

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (37.1%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Biomarin Pharmaceutical Inc. at 45.1% of the total. Among pediatrics clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$90,190in general payments, 2019–2025

Across 70 payments — averaging $1288.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biomarin Pharmaceutical Inc.$41K
Amgen$23K
PTC Therapeutics, Inc.$8K
Chiesi USA, Inc.$6K
Amicus Therapeutics, Inc.$5K
Immedica Pharma US, Inc.$4K
plus $4K from 3 others

$1,071,769in research payments, 2019–2025

Across 159 payments — averaging $6740.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Ultragenyx Pharmaceutical Inc.$1.1M
Chiesi USA, Inc.$19K

What the payments were for

Consulting fees$22,78325%
Speaking & faculty fees$31,95835%
Travel & lodging$33,48237%
Food & beverage$1,4252%
Education$5431%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biomarin Pharmaceutical Inc.	26	$40,691
Amgen(2 entities)	26	$22,820
PTC Therapeutics, Inc.	6	$7,637
Chiesi USA, Inc.	4	$6,265
Amicus Therapeutics, Inc.	2	$4,527
Immedica Pharma US, Inc.	2	$4,000
Applied Therapeutics, Inc.	2	$2,531
Zevra Therapeutics Inc	1	$1,647
Abbott	1	$73

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

RAVICTI$22,333
VOXZOGO 1.2mg$20,544
POMBILITI$4,527
OPFOLDA$4,527
LAMZEDE$4,325
Vimizim$3,300
Olpruva$1,647
Palynziq$250
Kuvan$125

How this compares

$90,190 in reported general payments places this provider in the 95th percentile of 5,361 pediatrics providers in Texas.

See all pediatrics providers in Texas →

Other pediatrics in Houston

Pedro PiedraHouston$729K
Carlos BacinoHouston$53K
Farida AbidHouston$50K
Lindsay CameronHouston$32K
Juan Torres SanchezHouston$31K
Martin YudovichHouston$24K
Raegan HuntHouston$23K
Michael PickettHouston$14K
Lara LeonhardtHouston$10K
Autumn AtkinsonHouston$9K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →